Brief: Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of Hypercholesterolemia
26/11/2024 13:08
Nov 26 (Reuters) - Esperion Therapeutics Inc ESPR.O :
* OTSUKA SUBMITS NEW DRUG APPLICATION IN JAPAN FOR BEMPEDOIC
ACID
IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
* ESPERION THERAPEUTICS INC - NO SERIOUS ADVERSE EVENTS
OBSERVED
IN BEMPEDOIC ACID TRIAL
Source text: ID:nGNX9ZL4zQ
Further company coverage: ESPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi